Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Clin Exp Urol. 2014 Apr 15;2(1):57-61.

Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma.

Author information

1
Department of Pathology, New York University School of Medicine, New York, NY.
2
Department of Medicine, New York University School of Medicine, New York, NY.
3
Department of Pathology, New York University School of Medicine, New York, NY ; Department of Urology, New York University School of Medicine, New York, NY ; Department of NYU Cancer Institute, New York University School of Medicine, New York, NY ; Department of Veterans Affairs New York Harbor Healthcare System, New York University School of Medicine, New York, NY.
4
Department of Urology, New York University School of Medicine, New York, NY.
5
Gene by Gene, Ltd. Houston, TX, USA.
6
Department of Pathology, New York University School of Medicine, New York, NY ; Department of NYU Cancer Institute, New York University School of Medicine, New York, NY.
7
Department of Pathology, New York University School of Medicine, New York, NY ; Department of Medicine, New York University School of Medicine, New York, NY ; Department of NYU Cancer Institute, New York University School of Medicine, New York, NY ; Department of Veterans Affairs New York Harbor Healthcare System, New York University School of Medicine, New York, NY.

Abstract

The microbiome is a new center of attention for studies on the pathogenesis of human disease by focusing on the alterations of all microorganisms living in a particular site or system of human body, referred as microbiota. Evidence suggests that microbiota could contribute to the pathogenesis of a number of chronic diseases, including cancers, both locally and remotely. Multiple mechanisms have been proposed and/or proven for the microbiota's role in tumorigenesis, such as via induction of chronic inflammation, genotoxicity, bacterium-mediated cell proliferation, and activation of procarcinogens. Emerging data suggest that indigenous microbiota in the urinary tract may play an important role in the tumorigenesis of urothelial carcinoma, similar to other tumors. Future studies are needed to adequately define the microbiota composition and correlate its change with urothelial carcinoma.

KEYWORDS:

Microbiome; bladder cancer; microbiota; urothelial carcinoma

PMID:
25126590
PMCID:
PMC4219294
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center